Experimental Antidepressant Drug Meets Clinical Trial Goals
June 2, 2009 by admin
An experimental drug for treating depression made by Clinical Data Inc has met preliminary goals in a study.
The drug is called vilazodone, and is for treating people who experience a type of depression called major depressive disorders.
The drug was tested in a study of people diagnosed with depression, compared to a placebo pill to determine if the drug actually works.
According to study results, participants taking vilazodone showed a reduced rate of depressive symptoms than those given the placebo.
Clinical Data hope to file to the FDA for approval of their drug in the very near future.
